Free Trial

Sensus Healthcare (SRTS) Competitors

Sensus Healthcare logo
$3.36 +0.01 (+0.30%)
As of 03:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SRTS vs. BFLY, TMCI, RXST, SNWV, NPCE, STIM, CATX, CLPT, OM, and NNOX

Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include Butterfly Network (BFLY), Treace Medical Concepts (TMCI), RxSight (RXST), Sanuwave Health (SNWV), NeuroPace (NPCE), Neuronetics (STIM), Perspective Therapeutics (CATX), ClearPoint Neuro (CLPT), Outset Medical (OM), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry.

Sensus Healthcare vs. Its Competitors

Butterfly Network (NYSE:BFLY) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.

In the previous week, Sensus Healthcare had 20 more articles in the media than Butterfly Network. MarketBeat recorded 22 mentions for Sensus Healthcare and 2 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.86 beat Sensus Healthcare's score of -0.16 indicating that Butterfly Network is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Butterfly Network
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sensus Healthcare
4 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by insiders. Comparatively, 8.9% of Sensus Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Butterfly Network presently has a consensus target price of $3.00, indicating a potential upside of 107.61%. Sensus Healthcare has a consensus target price of $8.00, indicating a potential upside of 138.24%. Given Sensus Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Sensus Healthcare is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Butterfly Network
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75
Sensus Healthcare
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Sensus Healthcare has lower revenue, but higher earnings than Butterfly Network. Sensus Healthcare is trading at a lower price-to-earnings ratio than Butterfly Network, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Butterfly Network$82.06M4.43-$72.49M-$0.28-5.16
Sensus Healthcare$41.81M1.32$6.65M-$0.06-55.97

Sensus Healthcare has a net margin of -2.26% compared to Butterfly Network's net margin of -71.79%. Sensus Healthcare's return on equity of -1.58% beat Butterfly Network's return on equity.

Company Net Margins Return on Equity Return on Assets
Butterfly Network-71.79% -30.53% -21.80%
Sensus Healthcare -2.26%-1.58%-1.41%

Butterfly Network has a beta of 2.45, meaning that its stock price is 145% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.34, meaning that its stock price is 34% more volatile than the S&P 500.

Summary

Sensus Healthcare beats Butterfly Network on 8 of the 15 factors compared between the two stocks.

Get Sensus Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SRTS vs. The Competition

MetricSensus HealthcareMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$54.99M$7.00B$5.71B$9.79B
Dividend YieldN/A1.32%3.77%4.10%
P/E Ratio-55.7527.3030.9125.28
Price / Sales1.3268.81404.2188.50
Price / Cash7.7622.1625.2228.45
Price / Book0.984.829.536.01
Net Income$6.65M$178.31M$3.26B$265.34M
7 Day Performance5.60%2.50%4.66%2.89%
1 Month Performance-22.63%0.23%5.35%1.61%
1 Year Performance-48.18%9.92%32.14%25.61%

Sensus Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SRTS
Sensus Healthcare
2.0759 of 5 stars
$3.36
+0.2%
$8.00
+138.2%
-48.3%$54.99M$41.81M-55.7540
BFLY
Butterfly Network
3.084 of 5 stars
$1.43
+1.8%
$3.50
+145.6%
+49.7%$346.20M$82.06M-5.09460Gap Up
TMCI
Treace Medical Concepts
2.3677 of 5 stars
$5.61
+5.1%
$10.52
+87.5%
+11.5%$335.83M$209.36M-6.60250
RXST
RxSight
1.4988 of 5 stars
$7.92
+1.5%
$17.50
+121.0%
-84.0%$316.97M$139.93M-11.82220Trending News
Short Interest ↑
SNWV
Sanuwave Health
2.3787 of 5 stars
$35.49
-2.1%
$49.00
+38.1%
N/A$310.55M$36.19M-7.7940Gap Up
NPCE
NeuroPace
3.3582 of 5 stars
$8.93
-0.7%
$17.00
+90.4%
+24.6%$294.86M$79.91M-10.63170News Coverage
Earnings Report
Short Interest ↑
Analyst Revision
STIM
Neuronetics
2.3155 of 5 stars
$4.66
+5.4%
$5.50
+18.0%
+198.2%$292.22M$74.89M-3.56180
CATX
Perspective Therapeutics
1.7069 of 5 stars
$3.89
+5.7%
$12.56
+222.8%
-73.2%$288.75MN/A0.0070News Coverage
Analyst Revision
CLPT
ClearPoint Neuro
1.7021 of 5 stars
$10.53
+5.3%
$19.67
+86.8%
+7.4%$279.89M$31.39M-13.86110Earnings Report
Analyst Revision
OM
Outset Medical
1.3465 of 5 stars
$14.16
-5.9%
$29.50
+108.3%
+33.4%$266.54M$113.69M-0.49520
NNOX
Nano-X Imaging
2.1229 of 5 stars
$4.75
+3.3%
$9.50
+100.0%
-38.7%$265.78M$11.28M-5.28190Earnings Report
Analyst Revision

Related Companies and Tools


This page (NASDAQ:SRTS) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners